Pacer Advisors
TARO

Pacer Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Pacer Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-68
Closed -$3K – 2602
2021
Q4 		$3K Sell
68
-28
-29% -$1.57K ﹤0.01% 2180
2021
Q3 		$6K Buy
96
+3
+3% +$208 ﹤0.01% 1425
2021
Q2 		$7K Hold
93
– – ﹤0.01% 1388
2021
Q1 		$7K Sell
93
-5
-5% -$380 ﹤0.01% 1516
2020
Q4 		$7K Buy
+98
New +$6.3K ﹤0.01% 1498

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Pacer Advisors's TARO Position: Q1 2022 in Review

Pacer Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2022, closing a stake of 68 shares — an estimated $3K sold.

Pacer Advisors first reported a position in TARO in Q4 2020 and held it in 5 quarters. The position peaked at $7K in Q2 2021. 69 funds tracked by Wall St. Rank hold TARO as of Q1 2022.

  • Pacer Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2022 after selling out during the quarter.
  • Pacer Advisors sold 68 Taro Pharmaceutical Industries Ltd. shares in Q1 2022, an estimated $3K.
  • Pacer Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2020 and held it in 5 quarters.
  • Pacer Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $7K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2022.

Based on Pacer Advisors's 13F filing for Q1 2022, filed 5 Apr 2022.